Myeloperoxidase Genotypes and Enhanced Efficacy of Chemotherapy for Early-Stage Breast Cancer in SWOG-8897

PURPOSE: Myeloperoxidase (MPO) generates reactive oxygen species and also activates xenobiotics. In a rigorous clinical trial (Southwest Oncology Group SWOG-8897), we examined relationships between genotypes and disease-free survival (DFS) among women treated for breast cancer, as well as those who...

Full description

Saved in:
Bibliographic Details
Main Authors: Ambrosone, Christine B., Barlow, William E., Reynolds, Wanda, Livingston, Robert B., Yeh, I-Tien, Choi, Ji-Yeob, Davis, Warren, Rae, James M., Tang, Li, Hutchins, Laura R., Ravdin, Peter M., Martino, Silvana, Osborne, C. Kent, Lyss, Alan P., Hayes, Daniel F., Albain, Kathy S.
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2009
Subjects:
Original Reports
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2799053/
https://ncbi.nlm.nih.gov/pubmed/19752340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.21.8669
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items